Institutional Ownership Aclaris Therapeutics, Inc. (ACRS)
This table provides information about the institutional ownership of Aclaris Therapeutics, Inc. (ACRS). We have compiled data on the 112 institutions that hold shares in the stock, with a total of 92.4 Million shares, which have been reported (via 13F filing form) to have a value of $135 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Two Sigma Investments, LP
New York, NY |
May 15, 2025 Q1 2025 |
820,264
shares
|
$1.2 Million
0.0% of portfolio
|
Q1 2025
Reduced 2.26%
|
|
|
Palo Alto Investors LP
Palo Alto, CA |
May 15, 2025 Q1 2025 |
776,028
shares
|
$1.13 Million
0.24% of portfolio
|
Q1 2025
Added 36.19%
|
|
|
Cantor Fitzgerald, L. P.
New York, NY |
May 15, 2025 Q1 2025 |
695,573
shares
|
$1.02 Million
0.02% of portfolio
|
Q1 2025
Added 595.57%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Jun 26, 2025 Q1 2025 |
555,953
shares
|
$811,691
0.0% of portfolio
|
Q1 2025
Added 29.72%
|
|
|
Stonepine Capital Management, LLC
Bend, OR |
May 14, 2025 Q1 2025 |
527,842
shares
|
$770,649
2.69% of portfolio
|
Q1 2025
Reduced 20.43%
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
498,721
shares
|
$728,132
0.0% of portfolio
|
Q1 2025
Added 464.68%
|
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
May 15, 2025 Q1 2025 |
460,842
shares
|
$672,829
0.0% of portfolio
|
Q1 2025
Reduced 20.0%
|
|
|
Aisling Capital Management LP
New York, NY |
May 13, 2025 Q1 2025 |
434,455
shares
|
$634,304
0.23% of portfolio
|
Q4 2022
Reduced 31.52%
|
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
407,525
shares
|
$594,986
0.0% of portfolio
|
Q1 2025
Added 27.64%
|
|
|
Jane Street Group, LLC
New York, NY |
May 19, 2025 Q1 2025 |
390,282
shares
|
$569,811
0.0% of portfolio
|
Q1 2025
Reduced 28.46%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
May 13, 2025 Q1 2025 |
354,849
shares
|
$518,079
0.0% of portfolio
|
Q1 2025
Added 48.1%
|
|
|
Squarepoint Ops LLC
New York, NY |
May 15, 2025 Q1 2025 |
348,917
shares
|
$509,418
0.0% of portfolio
|
Q1 2025
Added 19.13%
|
|
|
High Tower Advisors, LLC
Chicago, IL |
May 12, 2025 Q1 2025 |
316,064
shares
|
$461,453
0.0% of portfolio
|
Q1 2025
Added 20.2%
|
|
|
Walleye Capital LLC
Plymouth, MN |
May 14, 2025 Q1 2025 |
311,712
shares
|
$455,099
0.0% of portfolio
|
Q1 2025
Reduced 56.64%
|
|
|
Bridgeway Capital Management, LLC
Houston, TX |
May 15, 2025 Q1 2025 |
288,719
shares
|
$421,529
0.01% of portfolio
|
Q1 2025
Added 2.7%
|
|
|
Northern Trust Corp
Chicago, IL |
May 13, 2025 Q1 2025 |
269,086
shares
|
$392,865
0.0% of portfolio
|
Q1 2025
Added 53.61%
|
|
|
Raymond James Financial Inc
St. Petersburg, FL |
May 13, 2025 Q1 2025 |
250,805
shares
|
$366,175
0.0% of portfolio
|
Q1 2025
Added 62.49%
|
|
|
Man Group PLC
London, X0 |
May 15, 2025 Q1 2025 |
197,748
shares
|
$288,712
0.0% of portfolio
|
Q1 2025
Added 269.39%
|
|
|
Assenagon Asset Management S.A.
|
Jul 11, 2025 Q2 2025 |
184,585
shares
|
$269,494
0.0% of portfolio
|
Q2 2025
Reduced 72.92%
|
|
|
Graham Capital Management, L.P.
Rowayton, CT |
May 15, 2025 Q1 2025 |
177,558
shares
|
$259,234
0.01% of portfolio
|
Q1 2025
Added 1152.88%
|
|
|
Omers Administration Corp
Toronto, A6 |
May 14, 2025 Q1 2025 |
175,900
shares
|
$256,814
0.0% of portfolio
|
Q1 2025
Added 223.35%
|
|
|
Bank Of America Corp
Charlotte, NC |
May 15, 2025 Q1 2025 |
167,669
shares
|
$244,796
0.0% of portfolio
|
Q1 2025
Reduced 18.4%
|
|
|
Ikarian Capital, LLC
Dallas, TX |
May 15, 2025 Q1 2025 |
150,900
shares
|
$220,314
0.03% of portfolio
|
Q1 2025
Reduced 56.89%
|
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
May 15, 2025 Q1 2025 |
127,592
shares
|
$186,284
0.0% of portfolio
|
Q1 2025
Reduced 3.26%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
May 14, 2025 Q1 2025 |
123,100
shares
|
$179,726
0.0% of portfolio
|
Q4 2024
Reduced 11.69%
|